Therapeutic antibodies

ABT aims to develop a new class of therapeutic antibodies, which addresses limitations with current therapeutic antibodies and will improve the current antibody-based treatments.

By introducing modifications to the antibody, advantages are obtained in relation to:   

• Increased treatment duration
  

• Increased tissue accessibility
  

• Reduced side effects
  

• Improved effectivity

For more information about this project please contact us: abt@antibodytechnologies.net